Skip to main content
. 2017 Jul 19;38(7):1465–1470. doi: 10.1007/s00246-017-1685-7

Table 2.

Patient characteristics by time period

Pre-protocol Post-protocol
Total patients 733 158
 Male 421 (57%) 88 (43%)
 Female 312 (43%) 70 (44%)
 Trisomy 21 87 (12%) 22 (14%)
 22q11.2 deletion syndrome 28 (4%) 8 (5%)
Tested with one of 3 target tests 441 (60%) 121 (77%)
 Karyotype 307 (42%) 33 (21%)
 22q11.2 deletion testing 243 (33%) 23 (15%)
 Microarray 292 (40%) 94 (59%)
Untested patients 292 (40%) 37 (23%)